Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Germany.
Liver Cancer Center Heidelberg (LCCH), University Hospital Heidelberg, Germany.
Transpl Int. 2021 Apr;34(4):622-639. doi: 10.1111/tri.13824. Epub 2021 Feb 27.
The outcomes of split-liver transplantation are controversial. This study compared outcomes and morbidity after extended right lobe liver transplantation (ERLT) and whole liver transplantation (WLT) in adults. MEDLINE and Web of Science databases were searched systematically and unrestrictedly for studies on ERLT and its impact on graft and patient survival, and postoperative complications. Graft loss and patient mortality odds ratios (OR) and 95% confidence intervals (CI) were assessed by meta-analyses using Mantel-Haenszel tests with a random-effects model. Vascular and biliary complications, primary nonfunction, 3-month, 1-, and 3-year graft and patient survival, and retransplantation after ERLT and WLT were analyzed. The literature search yielded 10 594 articles. After exclusion, 22 studies (n = 75 799 adult transplant patients) were included in the analysis. ERLT was associated with lower 3-month (OR = 1.43, 95% CI = 1.09-1.89, P = 0.01), 1-year (OR = 1.46, 95% CI = 1.08-1.97, P = 0.01), and 3-year (OR = 1.37, 95% CI = 1.01-1.84, P = 0.04) graft survival. WL grafts were less associated with retransplantation (OR = 0.57; 95% CI = 0.41-0.80; P < 0.01), vascular complications (OR = 0.53, 95% CI = 0.38-0.74, P < 0.01) and biliary complications (OR = 0.67; 95% CI = 0.47-0.95; P = 0.03). Considering ERLT as major Extended Donor Criteria is justified because ERL grafts are associated with vasculobiliary complications and the need for retransplantation, and have a negative influence on graft survival.
劈离式肝移植的结果存在争议。本研究比较了成人扩展右半肝肝移植(ERLT)和全肝移植(WLT)的结果和发病率。系统地、无限制地在 MEDLINE 和 Web of Science 数据库中搜索了关于 ERLT 及其对移植物和患者存活率以及术后并发症影响的研究。使用 Mantel-Haenszel 检验和随机效应模型评估移植物丢失和患者死亡率的比值比(OR)和 95%置信区间(CI)。分析了 ERLT 和 WLT 后血管和胆并发症、原发性无功能、3 个月、1 年和 3 年移植物和患者存活率以及再次移植。文献检索产生了 10594 篇文章。排除后,有 22 项研究(n=75799 例成年移植患者)纳入分析。ERLT 与较低的 3 个月(OR=1.43,95%CI=1.09-1.89,P=0.01)、1 年(OR=1.46,95%CI=1.08-1.97,P=0.01)和 3 年(OR=1.37,95%CI=1.01-1.84,P=0.04)移植物存活率相关。WLT 移植物较少发生再次移植(OR=0.57;95%CI=0.41-0.80;P<0.01)、血管并发症(OR=0.53,95%CI=0.38-0.74,P<0.01)和胆并发症(OR=0.67;95%CI=0.47-0.95;P=0.03)。将 ERLT 视为主要扩展供体标准是合理的,因为 ERL 移植物与血管胆并发症和再次移植的需要相关,并对移植物存活率产生负面影响。